|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
Phase II Multicenter, Double-blinded Clinical Trial of SP160412 in the Temporary Relief of Mild to Moderate (i.e,First Degree) Sunburn
A phase II multicenter, double-blinded clinical trial of the safety and efficacy of
SP160412 in the temporary relief of mild to moderate, (i.e. first degree) sunburn
100 项与 Sephoris Pharmaceuticals LLC 相关的临床结果
0 项与 Sephoris Pharmaceuticals LLC 相关的专利(医药)
100 项与 Sephoris Pharmaceuticals LLC 相关的药物交易
100 项与 Sephoris Pharmaceuticals LLC 相关的转化医学